Miller Moth (Antigen Laboratories, Inc.)
Welcome to the PulseAid listing for the Miller Moth drug offered from Antigen Laboratories, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Antigen Laboratories, Inc. |
| NON-PROPRIETARY NAME: | Miller Moth |
| SUBSTANCE NAME: | SITOTROGA CEREALELLA |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRADERMAL; SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 1974-03-23 |
| END MARKETING DATE: | 0000-00-00 |
Miller Moth HUMAN PRESCRIPTION DRUG Details:
| Item Description | Miller Moth from Antigen Laboratories, Inc. |
| LABELER NAME: | Antigen Laboratories, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.05(g/mL) |
| START MARKETING DATE: | 1974-03-23 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 49288-0461_f1a31511-6642-4da5-82cf-67c9ca728bc6 |
| PRODUCT NDC: | 49288-0461 |
| APPLICATION NUMBER: | BLA102223 |
Other SITOTROGA CEREALELLA Pharmaceutical Manufacturers / Labelers:
